Dashboard
Manage Tickers

ELEV


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
' Medicare Part D Drug Plan Premiums Set t...
07/28/2025 20:29:42

https://www.wsj.com/health/healthcare/medicare-part-d-drug-plan-premiums-set-to-rise-16ef919c

elevation-oncology-license-agreement-with-cspc-megalith-biopharmaceutical-terminated-as-of-june-26-2025-termination-agreement-includes-mutual-release-of-claims
Elevation Oncology License Agreement With ...
07/02/2025 20:21:57

-SEC Filing

Core News & Articles
'Lawmakers Seek to Close VA Loophole That ...
06/23/2025 18:27:57

https://www.wsj.com/politics/policy/lawmakers-seek-to-close-va-loophole-that-funnels-billions-to-private-medicare-insurers-cfbe...

Core News & Articles
'Senate Republicans to Omit Medicare Advan...
06/16/2025 20:47:16

https://www.bloomberg.com/news/articles/2025-06-16/senate-republicans-to-omit-medicare-advantage-cuts-in-tax-bill?embedded-chec...

jmp-securities-reiterates-market-perform-on-elevation-oncologyto-market-perform
JMP Securities Reiterates Market Perform o...
06/10/2025 14:00:12

JMP Securities analyst Silvan Tuerkcan reiterates Elevation Oncology (NASDAQ:ELEV) from Market Perform to Market Perform.

this-mcdonalds-analyst-turns-bearish-here-are-top-4-downgrades-for-tuesday
This McDonald's Analyst Turns Bearish; Her...
06/10/2025 12:39:24

hc-wainwright--co-downgrades-elevation-oncology-to-neutral-lowers-price-target-to-036
HC Wainwright & Co. Downgrades Elevation O...
06/10/2025 11:17:37

HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Elevation Oncology (NASDAQ:ELEV) from Buy to Neutral and l...

william-blair-downgrades-elevation-oncology-to-market-perform
William Blair Downgrades Elevation Oncolog...
06/09/2025 19:06:04

William Blair analyst Andy Hsieh downgrades Elevation Oncology (NASDAQ:ELEV) from Outperform to Market Perform.

trading-halt-halt-status-updated-at-82500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:25:...
06/09/2025 12:25:04

concentra-biosciences-to-acquire-elevation-oncology-for-036-in-cash-per-share-of-elevation-oncology-common-stock-plus-one-non-tradeable-contingent-value-right
Concentra Biosciences To Acquire Elevation...
06/09/2025 12:03:16

Elevation Oncology, Inc. (NASDAQ:ELEV), an innovative oncology company focused on the discovery and development of selective ca...

trading-halt-halted-at-75500-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:55:00 a.m. ET - ...
06/09/2025 11:55:04

Core News & Articles
'Medicare Surfaces as Target for Cuts to P...
06/05/2025 18:08:51

https://www.bloomberg.com/news/articles/2025-06-05/medicare-surfaces-as-target-for-cuts-to-pay-for-trump-tax-bill?srnd=phx-poli...

Core News & Articles
'Medicare Surfaces as Target for Cuts to P...
06/05/2025 18:07:18

https://www.bloomberg.com/news/articles/2025-06-05/medicare-surfaces-as-target-for-cuts-to-pay-for-trump-tax-bill?srnd=phx-poli...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
05/29/2025 21:06:36

Core News & Articles
'CMS Rolls Out Aggressive Strategy To Enha...
05/21/2025 20:44:24

CMS Rolls Out Aggressive Strategy to Enhance and Accelerate Medicare Advantage Audits

elevation-oncology-q1-eps-024-misses-019-estimate
Elevation Oncology Q1 EPS $(0.24) Misses $...
05/15/2025 11:33:22

elevation-oncology-to-present-data-for-eo-1022-at-american-association-for-cancer-research-annual-meeting-2025
Elevation Oncology To Present Data For EO-...
03/25/2025 20:31:59

-- Abstract accepted for late-breaking poster presentation –-- EO-1022 is a potentially differentiated HER3 ADC being developed...

stephens--co-downgrades-elevation-oncology-to-equal-weight-lowers-price-target-to-1
Stephens & Co. Downgrades Elevation Oncolo...
03/24/2025 12:38:25

Stephens & Co. analyst Sudan Loganathan downgrades Elevation Oncology (NASDAQ:ELEV) from Overweight to Equal-Weight and ...

piper-sandler-downgrades-elevation-oncology-to-neutral-lowers-price-target-to-07
Piper Sandler Downgrades Elevation Oncolog...
03/21/2025 15:24:02

Piper Sandler analyst Biren Amin downgrades Elevation Oncology (NASDAQ:ELEV) from Overweight to Neutral and lowers the price...

citizens-capital-markets-downgrades-elevation-oncology-to-market-perform-maintains-price-target-to-7
Citizens Capital Markets Downgrades Elevat...
03/21/2025 15:10:27

Citizens Capital Markets analyst Silvan Tuerkcan downgrades Elevation Oncology (NASDAQ:ELEV) from Market Outperform to Marke...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION